INTRODUCTION
Aberrant intestinal microbiota composition and function, termed dysbiosis, is suggested to associate with many diseases Turnbaugh et al., 2006) . A dysbiotic state can be established in multiple ways, including intestinal infection (Lupp et al., 2007; Stecher et al., 2007) auto-inflammation (Devkota et al., 2012) , altered host genetics (Goodrich et al., 2014) , and dietary modulation (David et al., 2014) . Remarkably, disease-promoting dysbiotic microbiota in multiple mouse models harbors dominance, upon fecal transfer, over a previously stable wild-type (WT) microbiota, leading to transferable disease susceptibility (Couturier-Maillard et al., 2013; Elinav et al., 2011; Garrett et al., 2007; Henao-Mejia et al., 2012; Ivanov et al., 2009 ). The host immune system participates in the organization of the ''healthy'' host-microbial interface, with mechanisms ranging from IgA and mucus secretion to AMP production (Hooper et al., 2012) . However, the means by which the indigenous microbiota contributes to its ''healthy'' niche construction, and the mechanisms driving the formation of a dysbiotic microbiota and its persistence in an invaded host, remain poorly understood. To study in detail the mutualistic host-and microbiota-regulated mechanisms determining the normal and disease-associated intestinal interface, we employed the NLPR6 inflammasome deficiency model, in which host innate immune genetic deficiency is associated with development of an aberrant microbial configuration driving disease susceptibility (Elinav et al., 2011; Henao-Mejia et al., 2012) . Inflammasomes are multi-protein complexes consisting of one of several upstream NOD-like receptor (NLR) proteins, the adaptor apoptosis-associated speck-like protein containing a CARD (ASC) and the effector caspase-1. Upon receipt of defined sets of transcriptional and post-translational signals, inflammasomes are assembled, become active through auto-cleavage of pro-caspase-1, and process the catalytic activation of IL-1b and IL-18 (Martinon et al., 2009) .
The NLRP6 inflammasome is a key regulator of colonic homeostasis (Elinav et al., 2011; Hu et al., 2013; Wlodarska et al., 2014) . NLRP6 is predominantly expressed in intestinal epithelial cells, including goblet cells (Elinav et al., 2011; Gremel et al., 2015; Wlodarska et al., 2014) , where it was found to be essential for mucosal self-renewal, proliferation, and mucus secretion (Chen et al., 2011; Normand et al., 2011; Wlodarska et al., 2014) . Likewise, ASC and caspase-1 are co-expressed in intestinal epithelial cells, yet no biochemical evidence of their assembly into an NLRP6 inflammasome has been demonstrated to date. Mice deficient in NLRP6, ASC, or caspase-1 feature a distinct form of dysbiosis that drives a contextspecific propensity for intestinal auto-inflammation, inflammation-induced colorectal cancer and features of the ''metabolic syndrome'' (Anand and Kanneganti, 2012; Elinav et al., 2011; Henao-Mejia et al., 2012; Ikuta et al., 2013) . It is postulated that factors secreted by the WT microbiota activate and modulate the NLRP6 inflammasome, but no such factors have been discovered to date. Moreover, the mechanisms by which inflammasome deficiency leads to dysbiosis and how this disease-causing ecosystem assumes dominance upon transfer into a WT host remain elusive.
In this study, we highlight principles by which the host and its microbiota cooperatively utilize inflammasome signaling in the formation and stabilization of the host-microbiota interface. We identify microbial metabolites that signal to the NLRP6 inflammasome, thereby activating host immune circuits to orchestrate an antimicrobial program, which optimizes commensal colonization and persistence. We demonstrate that alteration of this crosstalk is sufficient to induce a state of dysbiosis, and the altered microbiota is able to exploit these pathways in conferring a preferential microenvironment for its colonization in an invaded host.
RESULTS
The Microbiota Modulates the NLRP6 Inflammasome and Downstream Antimicrobial Peptide Secretion We began our investigation by studying the effects of commensal bacterial colonization on inflammasome signaling in the WT setting. We identified the gut microbiota to be critically important for inflammasome activation, as its absence in germ-free (GF) mice resulted in abolished caspase-1 auto-cleavage (Figures 1A and 1B) . This severely altered inflammasome activity, coupled with reduced Il18 mRNA ( Figure S1A ), resulted in abrogated levels of colonic IL-18 in WT GF mice ( Figure 1C) . Similarly, WT mice treated with broad-spectrum antibiotics (see Experimental Procedures) featured decreased mRNA ( Figure S1B ) and protein levels of IL-18 ( Figure 1D ). To corroborate the role of the microbiota in inducing mucosal IL-18, we examined the levels of IL-18 in the neonatal period, in which newborn mammals feature progressive microbial colonization, accompanied by intestinal barrier formation and immune system maturation. Indeed, intestinal IL-18 levels progressively increased over the first 5 weeks of post-natal development, paralleling microbial colonization (Figures 1E and S1C) (Kempster et al., 2011) . Together, these results suggest that WT commensal bacterial colonization regulates intestinal inflammasome assembly by providing a ''signal I'' (transcription of inflammasome components) and possibly a ''signal II'' (inducing inflammasome assembly), resulting in steady-state mucosal IL-18 secretion.
We next determined the consequences of commensal-mediated IL-18 induction on the host mucosal microenvironment, by performing RNA sequencing (RNA-seq) of colonic tissue from WT and Il18 À/À mice. We grouped host transcripts into Gene Ontology functional categories and evaluated differential expression of these categories between WT and Il18 À/À mice ( Figure S1D ). One of the most differentially represented categories included anti-microbial pathways ( Figure 1F ), suggesting a role for IL-18 in regulating the anti-microbial program of the colonic mucosa. Among the AMPs induced by IL-18 were ITLN1, RELMb, and members of the angiogenin family (Figures 1G-1I and S1E), for which a microbicidal activity has been previously reported (Artis et al., 2004; Tsuji et al., 2001) . Of these, angiogenin-4 (Ang4) expression has been suggested to be influenced by the intestinal microbiota (Hooper et al., 2003) . Indeed, GF mice featured nearly undetectable levels of Ang4 (Figure S1F) , as well as ITLN1 and RELMb (Figures S1G and S1H), while microbial colonization during early development progressively induced AMP expression in newborn WT mice ( Figure 1J ). Bone marrow chimera experiments, using WT or Il18 À/À mice as either donors or recipients of bone marrow transplants, indicated that intestinal IL-18 is primarily produced, under homeostatic conditions, by the non-hematopoietic compartment (Figures (G-O) Expression levels of the indicated AMPs in WT and Il18 À/À colonic tissue (G-I), during early stages of post-natal colonization (J), in the colon of bone marrow chimeras generated from WT and Il18 À/À mice (K), in colonic explants from germ-free mice cultured with IL-18 compared to controls (L), in IL-18 injected germfree mice compared to SPF controls (M and N), and in colonic explants cultured with or without the NF-kB inhibitor Bay 11-7085 (O). Data are expressed as mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001. Pairwise comparison was performed using Student's t test, unless stated otherwise.
Results shown are representative of three (A-D) or two (E-O) independent repeats (n = 3-13 per group). See also Figure S1 . , and Il18 À/À mice. S1I and S1J), and IL-18 originating from this source is necessary for AMP induction ( Figure 1K ). Administration of IL-18 under sterile conditions to GF colon explants increased the levels of colonic AMPs ( Figure 1L ). In vivo administration of IL-18 to WT GF mice partially rescued AMP levels ( Figures 1M,  1N , and S1K), correlating with colonic levels of IL-18 (Figure S1L) , while transcript levels of IL-18 remained unaffected ( Figure S1M ). Induction of AMPs by IL-18 was dependent on NF-kB signaling, since NF-kB inhibition prevented AMP induction ( Figure 1O ). Altogether, these results suggest that microbiota-induced colonic IL-18 is both necessary and sufficient for the regulation of intestinal anti-microbial peptide production. We next aimed to determine whether IL-18-mediated induction of colonic anti-microbial activity is dependent on epithelial NLRP6 inflammasome activity, previously found to regulate homeostatic IL-18 levels (Elinav et al., 2011 ). An ASC-dependent NLRP6 inflammasome complex was found in vitro (upon expression in HEK293T cells) (Grenier et al., 2002) Figures 2E and S2C ).
An aberrant AMP profile of Asc À/À mice was also noted by RNAseq of colons obtained from genetically identical mice housed in an independent animal facility ( Figures S2D-S2G ). To validate these results, we further focused on colonic IL-18 and the prototypical AMP Ang4 and compared their levels in WT mice to those in Nlrp6
, and Nlrp3 À/À mice.
While mice lacking NLRP3 had normal levels of colonic IL-18 and Ang4, Nlrp6
, and Casp1/11 À/À mice featured a marked reduction in both IL-18 and Ang4, suggesting that the NLRP6 inflammasome is required for IL-18 production upstream of AMP induction (Figures 2F and S2H) . Ang4 reduction at the protein level was confirmed by targeted massspectrometry for Ang4 peptides (Figures 2G and 2H) . In vivo administration of recombinant IL-18 into mice lacking NLRP6, ASC, or caspase-1/11 restored IL-18 and AMP levels (Figures 2I, 2J, and S2I-S2L), demonstrating that IL-18 is sufficient for AMP expression downstream of inflammasome signaling.
Since both the microbiota and NLRP6 inflammasome were required for IL-18 and AMP induction, we hypothesized that the microbiota may activate NLRP6 upstream of IL-18 secretion. Indeed, while induction of IL-18 transcription in response to microbial colonization of GF mice functioned normally in both WT and Nlrp6 À/À mice ( Figure S2M ), activation of caspase-1, secretion of mature IL-18 protein, and concomitant upregulation of Ang4 mRNA were induced upon colonization of GF WT mice, but were severely impaired upon conventionalization of GF Nlrp6 À/À mice ( Figures 2K-2M and S2N ). Moreover, sterile administration of IL-18 into GF Nlrp6 À/À mice ( Figure S2O ) rescued this defect and induced Ang4 expression ( Figure 2N ), indicating that the addition of IL-18 bypasses the need for both the presence of a microbiota and intact inflammasome signaling and suffices to induce a normal anti-microbial program. Together, these data uncover a pathway by which the microbiota induces NLRP6 inflammasome signaling to produce IL-18, which in turn activates an AMP program in the colonic mucosa.
The Inflammasome-Antimicrobial Peptide Axis Regulates Intestinal Microbial Composition
We next assessed whether the above NLRP6-IL-18-AMP axis is involved in control of microbiota composition. Nlrp6
mice were recently shown to harbor a dysbiotic microbiome configuration (Elinav et al., 2011) . However, whether inflammasome deficiency directly drives dysbiosis (as opposed to cross-generational or facility-related dysbiosis) remained to be investigated. We therefore analyzed, using 16S rDNA sequencing, the temporal microbial composition of GF Nlrp6 À/À or WT mice that were allowed to spontaneously conventionalize at our vivarium (termed ex-GF mice). Notably, ex-GF Nlrp6 À/À mice gradually shifted their microbial community composition toward the dysbiotic configuration of Nlrp6 À/À mice that had been housed in our specific pathogen-free (SPF) vivarium for multiple generations (Figures 3A and 3B) . Two months following colonization, the microbiota composition of ex-GF Nlrp6 À/À mice became similar to that of SPF Nlrp6 À/À mice. This shift was accompanied by a gradual reduction in alpha-diversity down to the level of SPF Nlrp6 À/À mice ( Figure 3C ). Indeed, as early as 3 weeks from the start of spontaneous conventionalization, the gut microbiota of newly colonized Nlrp6 À/À mice became profoundly different from that of concomitantly conventionalized ex-GF WT mice ( Figure 3D ). NLRP6 inflammasome-induced dysbiosis was present across vivaria, as exemplified by similar composition and function of Nlrp6 See also Figure S2 .
results demonstrate that the intestinal inflammasome-deficient microenvironment is associated with a microbial ''signature'' that is independent of housing conditions and can be acquired de novo upon colonization of GF mice.
To determine whether the reduction of intestinal IL-18 and AMP levels is responsible for the inability of inflammasome-deficient mice to develop a normal microbial community structure, we administered recombinant IL-18 to WT, Nlrp6
À/À mice and determined the changes in bacterial composition. While the microbiota of WT mice was only mildly affected by the injection of IL-18, the microbiota of Nlrp6 (B and C) Relative distances (B) and alpha diversity rarefaction (C) between different stages of ex-germ-free Nlrp6 À/À mouse colonization and SPF Nlrp6 À/À mice.
(D) PCoA of fecal microbiota from ex-germ-free (GF) WT and Nlrp6 À/À mice, 3 weeks following spontaneous colonization.
(E-G) PCoA (E), relative distance (F), and alpha diversity (G) of OTU abundance observed in WT and Casp1/11 À/À mice with or without injection of IL-18.
(H and I) Relative distance (H) and alpha diversity (I) of microbiota between WT and Asc À/À mice with or without in vitro addition of Ang4.
Data are expressed as mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001. Pairwise comparison was performed using Student's t test, all other comparisons were performed using ANOVA. Results shown are representative of two independent repeats (n = 2-5). See also Figure S3 . and 3G). Likewise, administration of recombinant Ang4 to anaerobic in vitro microbiome cultures of Asc À/À mice partially restored beta-and alpha-diversity ( Figures 3H and 3I ), corroborating Ang4 as one of the microbiome-modulating effectors downstream of IL-18. Altogether, these data indicate that the identified NLRP6-IL-18-AMP pathway is involved in de novo determination of the normal intestinal community composition and stability, while its absence drives the development of dysbiosis.
Dominant Takeover of a Dysbiotic Microbiota upon Cohabitation through Suppression of Inflammasome Activity
One hallmark of the dysbiotic microbiota in inflammasomedeficient mice is its ability to dominantly transfer to genetically intact mice. Since the IL-18-AMP axis drives the establishment of a normal or dysbiotic microbiome, we determined whether this pathway also plays a role in the transmissibility of the aberrant microbiota composition into WT hosts. To this end, colonized WT mice were cohabitated for 4 weeks with either WT mice and designated colonized recipients (crWT(WT)), or cohabitated with Asc À/À mice and designated crWT(Asc À/À ) ( Figure 4A ). Cohousing equilibrated the microbiota between cohabitated partners, leading to the establishment of dysbiosis in crWT(Asc À/À ) mice as compared to the genetically identical crWT(WT) mice ( Figure S3G ). Surprisingly, cohousing with Asc À/À mice reduced colonic IL-18 levels in recipient WT mice (crWT(Asc À/À )) ( Figure 4B ). This IL-18 suppression was independent of genetic background and similarly developed when outbred Swiss Webster mice were used as cohoused WT partners ( Figure 4C ). These results suggested that the dysbiotic microbiota from inflammasome-deficient mice suppresses colonic IL-18 levels when transferred into WT recipients, regardless of their strain.
To enable a simplified transmissibility system, we cohabitated GF WT mice with either WT mice (designated germ-free recipient, grWT(WT)) or Asc À/À mice (designated grWT(Asc À/À )) (Figure 4A) . Expectedly, this led to full transfer of their respective microbiota composition and diversity to the cohoused GF partners (data not shown), so that both the WT and dysbiotic composition stably persisted in the genetically intact, previously GF mice. Strikingly, and similar to the above observation in co-housed SPF WT mice, colonic IL-18 levels in recipient grWT(Asc À/À ) mice were significantly reduced as compared to grWT(WT) mice ( Figure 4D ). As above, this suppressive phenomenon was present regardless of the genetic background of recipient ex-GF mice ( Figure 4E ). These differences in colonic IL-18 protein levels did not result from alterations in transcript levels of IL-18 or NLRP6 inflammasome components ( Figures S3H-S3J ), suggesting that the microbiome-mediated effects were influencing inflammasome activation (''signal II'') but not the transcription of its components (''signal I''). Indeed, caspase-1 cleavage was abrogated in grWT(Asc Figure 4H ), including a reduction in Ang4 and RELMb production ( Figures 4I, 4J , S3K, and S3L). Continuous IL-18 replenishment of recipient WT mice throughout the cohousing period partially prevented dominant transmission of the dysbiotic microbiota configuration from inflammasome-deficient mice ( Figure 4K ), resulting in an increased compositional similarity between IL-18-injected cohoused mice and WT controls (Figure 4L) . Together, these findings demonstrate that the dysbiotic microbiota stemming from inflammasome-deficient mice modulates inflammasome signaling upon transfer to a new WT host. As a consequence, the anti-microbial milieu of the new colonization microenvironment changes to resemble the dysbiotic niche of origin and allows for community persistence of the invading microbiome.
Microbiota Metabolites Modulate NLRP6 Inflammasome Signaling and Antimicrobial Pathways To determine the mechanism by which the microbiota modulates inflammasome signaling in the WT and dysbiotic states, we performed shotgun metagenomic sequencing of grWT(WT) and grWT(Asc À/À ) mice and found their respective microbiota to feature a large number of differentially abundant functional KEGG modules ( Figure 5A ). Many of the altered pathways involved the generation of small metabolites downstream of energy and nutrient metabolism, including amino acid and polyamine metabolism ( Figure 5A ). These changes were consistent across vivaria ( Figures S4A and S4B) .
Since metabolites are considered pivotal mediators of hostmicrobiota communication (Shapiro et al., 2014) , we hypothesized that microbiota-modulated metabolites may take part in regulation of NLRP6 inflammasome signaling and downstream anti-microbial pathways. To this end, we performed a metabolomic screen of cecal content of grWT(WT) mice as compared to grWT(Asc À/À ) mice. We found more than 70 metabolites to feature significantly differential levels between these genetically identical recipients ( Figure 5B ), among them amino acids and polyamines. Metabolites enriched in the grWT(WT) as compared to grWT(Asc À/À ) mice, potentially being microbiota-associated inflammasome activators, included the bile acid conjugate taurine, carbohydrates, and long-chain fatty acids ( Figure S4C ). These were tested for inflammasome signaling modulation, by culturing with sterile WT colonic explants and measuring their effect on IL-18 induction ( Figure 5C ), with taurine featuring the strongest dose-dependent inductive activity ( Figure 5D ). Taurine depletion from the intestinal lumen of grWT(Asc À/À ) mice correlated with a higher metagenomic abundance of the taurine transport system that is required for taurine uptake into bacterial cells and subsequent conjugation to secondary bile acids ( Figure S4D ). In colonic explants, taurine induced IL-18 secretion by triggering intestinal inflammasome activation and enhanced caspase-1 cleavage ( Figures 5E and 5F ), while neither influencing IL-18 transcript levels ( Figure S4E ) nor cell death ( Figure S4F ). Consequently, taurine treatment also induced upregulation of AMPs ( Figure 5G ). This induction of IL-18 was dependent on NLRP6, but not on NLRP3 (Figures 5H and  S4G) . Together, these results suggest that taurine is a microbiota-dependent positive inflammasome modulator responsible ) mice that were injected with either PBS or IL-18, followed by a fecal microbiota analysis. WT mice serve as controls. Data are expressed as mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001. Pairwise comparison was performed using Student's t test, unless stated otherwise. Results shown are representative of two to four independent repeats (n = 3-6 per group). See also Figure S3 . (legend continued on next page) for enhanced NLRP6 inflammasome-induced IL-18 secretion upon intestinal microbial colonization.
We next sought to identify metabolites that are involved in the microbiota-induced suppression of inflammasome signaling upon dysbiosis transfer into a WT host. To this end, we focused on metabolites enriched in grWT(Asc À/À ) as compared to grWT(WT) mice ( Figure S4H ) and screened the most differentially abundant metabolites as potential inflammasome suppressors using the colonic explant system. The two strongest suppressors of IL-18 secretion were histamine and spermine ( Figure 5I ), both found to be over-represented in colons of grWT(Asc À/À ) ( Figure S4H ). The accumulation of spermine in the lumen of grWT(Asc À/À ) mice was in line with the metagenomic enrichment of the polyamine biosynthesis and transport pathways that are required for the conversion of ornithine into spermine (Figure S4I ). These differences were mainly accounted for by members of the Lactobacillus genus ( Figures S4J and S4K ). Higher histamine levels in grWT(Asc À/À ) mice were in line with both increased histidine biosynthesis and transport pathways, as well as decreased histidine degradation ( Figure S5A ). A number of bacterial genera contributed to these histamine-related pathways ( Figures S5B-S5D ). Both histamine and spermine featured concentration-dependent IL-18 suppressive functions in the colonic explant-based validation screen ( Figures 5J and 5K) , while no change in IL-18 mRNA or cell death was observed ( Figures S5E and S5F ). Putrescine, a metabolite structurally similar to spermine, equally suppressed IL-18 in colon explants ( Figure S5G ).
Intestinal IL-18 suppression mediated by spermine and histamine resulted from a reduction in NLRP6 inflammasome assembly, as indicated by reduced caspase-1 processing ( Figures  5L-5O ) and decreased IL-18 protein levels seen in Nlrp3
À/À explants ( Figure S5H ). Of note, metaboliteinduced inflammasome suppression by either spermine or histamine could be rescued by concomitant administration of taurine ( Figure 5P ), suggesting that relative in vitro contribution of metabolites determine the overall activation of the NLRP6 inflammasome and downstream cytokine production. To validate the ex vivo colonic explant results, we employed colonic spheroids, an organ-like system amenable to long-term culture (Miyoshi and Stappenbeck, 2013) . As in explants, taurine administration to WT but not to Nlrp6 À/À organoids induced IL-18 secretion ( Figures S5I and S5J ), while not affecting organoid growth or morphology ( Figure S5K ). Additional supplementation with histamine and spermine diminished the taurine-mediated increase in IL-18 production ( Figures S5I and S5J ), while likewise not affecting spheroid growth or morphology ( Figure S5K ). To provide in vivo validation to the above metabolite activities and to further characterize their effects on the host-microbiome interface, we administered taurine to mice in the drinking water. This led to a marked activation of colonic caspase-1 (Figures 6A  and 6B ), IL-18 secretion ( Figure 6C) , and epithelial Ang4 production ( Figure 6D ), while not affecting IL-18 mRNA levels (Figure S6A) . These metabolite-induced epithelial changes were not accompanied by alterations in major colonic lamina propria hematopoietic cell populations ( Figure S6B ). These and our previous results (Figure 1) suggested that taurine may constitute a microbial ''signal II'' for the activation of the colonic NLRP6 inflammasome. To test this notion directly, we administered to GF WT mice either LPS (a known ''signal I''), taurine, or both. Indeed, LPS, but not taurine, potently induced colonic mRNA of Il18 ( Figure 6E ). However, caspase-1 activation, IL-18 secretion, and subsequent Ang4 production were only induced when both LPS and taurine were co-administered (Figures 6F-6H and S6C). Taurine's ''signal II'' function required an intact NLRP6 inflammasome, since no IL-18 induction was observed in taurine-administered Asc À/À or Nlrp6 À/À mice ( Figure 6I ). In contrast to taurine, in vivo administration of histamine and spermine reduced the levels of activated caspase-1 ( Figures 6J and  6K ), while not altering the composition of hematopoietic cells in the lamina propria ( Figure S6D ). These data verify the in vivo effects of the identified metabolites and suggest that the microbial ''signal II'' for NLRP6 inflammasome activation has distinct molecular identities in the form of microbiota-related metabolites. Administration of mice with taurine, histamine, or spermine in drinking water induced compositional changes in the intestinal microbiota ( Figures 6L, 6M , S6E, and S6F), which did not occur upon taurine administration to Asc À/À or Nlrp6 À/À mice ( Figures   6N, 6O , and S6G). Anaerobic microbiota cultures supplemented with taurine, histamine, or spermine did not feature significant compositional alterations ( Figure S6H ), further indicating that the metabolites do not act directly on commensal bacteria, but require signaling through the host to alter microbial ecology. Metabolite treatment also induced pronounced compositional changes in the epithelial-adherent microbiota, as determined by 16S sequencing and electron microscopy ( Figures 7A, 7B , and S6I-S6K). Together, these results identify distinct microbiome-modulated metabolites as in vitro and in vivo regulators of the NLRP6 inflammasome and downstream control of microbiota composition.
(D) IL-18 production by WT colon explants cultured with increasing doses of taurine. (E and F) Immunoblot (E) and quantification (F) of pro-caspase-1 (p45) and cleaved caspase-1 (p20) in colon tissue following 12 hr incubation with taurine.
(G) Ang4 expression in WT explants cultured with taurine for 8 hr.
(H) IL-18 production by WT and Nlrp6 À/À colon explants cultured with taurine. (legend continued on next page)
Restoration of the Inflammasome-Antimicrobial Peptide Axis Ameliorates Colitis Finally, we sought to determine whether the identification of the metabolite-IL-18-AMP axis has functional significance in disease settings, with a focus on inflammatory bowel disease (IBD). This auto-inflammatory disorder is driven by an impaired host-microbiota microenvironment and modeled by intestinal auto-inflammation mediated by a dysbiotic microbiota configuration in NLRP6 inflammasome-deficient mice (Elinav et al., 2011) . To determine the potential of the identified metabolites to ameliorate colonic auto-inflammation, taurine was administered in the drinking water to naive WT mice for 2 weeks and dextran sodium sulfate (DSS) colitis was induced. Taurinetreated mice featured improved weight loss ( Figure 7C ), reduced colitis severity ( Figures 7D-7F and S7A) (Shimizu et al., 2009; Zhao et al., 2008) , enhanced survival ( Figure 7G ) and improved mucosal barrier integrity as indicated by a reduced systemic FITC-dextran influx, decreased hepatic bacterial load, and sustained epithelial tight junction integrity ( Figures S7B-S7E) . Importantly, taurine's beneficial effects were also observed when taurine administration was stopped before induction of DSS colitis ( Figures S7F-S7I ), suggesting that the microbial changes, rather than any direct anti-inflammatory effects, were responsible for the amelioration of auto-inflammation. Taurine failed to have beneficial effects when administered to WT mice treated with broad-spectrum antibiotics ( Figures 7C-7F ), GF WT mice ( Figures S7J and S7K ), or mice lacking either ASC or NLRP6 ( Figures 7H, 7I , S7L, and S7M), suggesting that its activity requires an intact NLRP6 inflammasome and presence of the microbiota. In contrast to taurine, histamine treatment exacerbated DSS colitis in WT mice, an effect that was prevented when mice were concomitantly treated with antibiotics ( Figures  S7N and S7O) , further underlining the microbiome-dependency of the metabolite-mediated modulation of inflammation. As inflammasome-deficient mice were resistant to taurinemediated improvement of colitis, we tested whether an intervention targeting host signaling downstream of the NLRP6 inflammasome would improve disease severity in these mice. To this aim, we intraperitoneally (i.p.) administered twice-daily IL-18 or vehicle control to Asc À/À mice for 2 weeks, followed (after cessation of IL-18 treatment) by induction of DSS colitis. Indeed, administration of IL-18 prior to induction of colonic inflammation diminished colitis severity in Asc À/À mice, as assessed by reduced weight loss ( Figure 7J ) and an improved colonoscopy score ( Figures 7K and 7L ). Together, these results suggest that metabolite administration can modulate inflammasome signaling and downstream microbial composition, host physiology, and disease susceptibility.
DISCUSSION
In this study, we characterize a molecular mechanism contributing to the construction of a symbiotic intestinal microenvironment. We identify a set of microbiota-modulated metabolites whose integrative activity drives NLRP6 inflammasome activation and downstream epithelial IL-18-induced AMP secretion, thereby providing favorable conditions for WT microbiota colonization. Inflammasome deficiency causes an aberrant AMP program, leading to formation of a dysbiotic microbiota that acquires inflammasome-suppressive capabilities through an altered metabolite profile. Upon invasion into a WT host, hijacking and suppression of NLRP6 inflammasome signaling leads to modification of its anti-microbial landscape toward one that resembles the invading microbiota environment of origin, thereby ensuring its persistent colonization and conferring competitive advantage over the invaded host's microbiota. Of note, in addition to IL-18's roles in steady-state intestinal niche regulation, it features distinct and equally important functions during an inflammatory response. As demonstrated by Nowarski et al. (2015) in this issue of Cell, IL-18 drives intestinal auto-inflammation and breakdown of mucosal barrier integrity, through direct transcriptional effects exerted on goblet cells, impacting their maturation and function. Temporal and spatial integration of these IL-18-driven processes in orchestrating the mucosal immune response merit further studies.
Using an integrated metabolomics-metagenomics approach, we identify the organic acid taurine as a mucosal inflammasome activator and the metabolites histamine and spermine as inflammasome inhibitors. Taurine is a bile acid component modulated by commensal bacteria, which plays multiple roles in regulation of immune and metabolic processes (Brestoff and Artis, 2013) . Histamine and the polyamine spermine are metabolites produced by both the microbiota and the host. Inflammasome deficiency creates a microenvironment favoring the outgrowth of commensals that are capable of polyamine synthesis ( Figures  S4I-S4K ), as well as differential expression of histamine production and degradation pathways ( Figures S5A-S5D) , thereby leading to an accumulation of intestinal spermine and histamine.
The downstream consequence of these shifts in intestinal metabolites is the generation of a set of integrative signals to the host epithelium. Signal I recognizes microbial presence, primarily by sensing of Toll-like receptor ligands. Signal II may assess microbial function, by sensing of metabolite levels, indicative of commensal activity. Combinatorial metabolite levels may thus serve as a ''rheostat'' of microbiota function in distinct environmental scenarios. A combination of high taurine and low spermine/histamine levels provides an inflammasome-activating (E-H) WT germ-free mice were drinking taurine and on day 7 administered with LPS. IL-18 expression in the colon (E), immunoblot quantifications of procaspase-1 (p45) and cleaved caspase-1 (p20) (F), IL-18 production by colon explants (G), and colonic Ang4 expression (H). signal, resulting in formation of a supportive host microenvironment for the WT microbiota. In contrast, dysbiotic microbiotainduced low taurine and high spermine/histamine levels provides an inflammasome suppressive signal, driving an altered host-microbial interface that supports the dysbiotic microbiota. The involvement of more metabolites in these complex interactions, and the molecular mechanisms by which they influence innate immune signaling, will constitute an exciting area of future research.
Equally interesting is the ability of certain dysbiotic microbiome configurations to invade a stable microbiota. ''Inflammasome hijacking'' highlights one such mechanism, in which the microbiome is able to modulate host signaling to enable optimal colonization conditions. Microbiota-mediated intestinal secretory IgA modulation represents another such ''host hijacking'' example (Moon et al., 2015) . Our findings, demonstrating that a given microbial configuration may persist and ''synchronize'' colonization conditions across genetically different hosts, provide the functional counterpart to the recent finding that host genetics influence microbial composition (Goodrich et al., 2014) . Deciphering these and other unrecognized molecular mechanisms driving microbiota resilience may enable to elucidate the ability of certain microbiota to transmit disease susceptibility between individuals.
Finally, our study suggests that microbiota composition and function may be therapeutically exploited by methods different from, and complementary to, probiotic and prebiotic approaches. As such, rather than attempting to change the microbiota itself, such ''postbiotic'' treatment employing or manipulating downstream microbiota-produced or microbiota-modulated metabolites may enable to control the host-microbiota interface. Harnessing the endogenous physiological forces shaping the microbiota to drive it from disease-prone toward a healthy configuration may circumvent the strong inter-individual variability in microbiota composition that severely limits effective pre-and pro-biotic treatment. Such novel therapeutic approaches may potentially present opportunities for rational design of microbiota-modulating interventions in a variety of multi-factorial disorders.
EXPERIMENTAL PROCEDURES
A detailed description of experimental procedures can be found in the Supplemental Experimental Procedures.
Mice
C57Bl/6 mice were purchased from Harlan and allowed to acclimatize for 2 weeks before experimentation. GF mice were bred at the Weizmann Institute germ-free facility. In experiments where both C57Bl/6 and outbred Swiss Webster mice were used, the respective strain is indicated. In all experiments, age-and gender-matched 8-to 9-week-old mice were used. In cohousing experiments, age-matched female mice were cohoused at 1:1 ratios for 4 weeks. Fresh stool samples were collected in tubes, snap frozen in liquid nitrogen, and stored at À80 C until DNA isolation. Broad-spectrum antibiotics included a combination of vancomycin (0.5 g/l), ampicillin, kanamycin, and metronidazole (all 1 g/l) in the drinking water. In spontaneous colonization experiments, GF WT mice and GF Nlrp6 À/À mice (both C57Bl/6) were removed from sterile isolators and housed in SPF conditions. Interfacility analysis refers to: Weizmann Institute of Science (facility A) and University of Massachusetts Medical School (facility B). All experimental procedures were approved by the local IACUC.
Taxonomic Microbiota Analysis
Frozen fecal samples were processed for DNA isolation using the MoBio PowerSoil kit according to the manufacturer's instructions. Libraries were sequenced using the Illumina MiSeq platform. Data were processed using the QIIME analysis pipeline (Caporaso et al., 2010) .
Statistical Analysis
Data are expressed as mean ± SEM. P values < 0.05 were considered significant (*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001). Pairwise comparisons were performed using Student's t test. Mann-Whitney U test was used when the distribution was not known to be normal. Comparison between multiple groups was performed using ANOVA, and FDR correction was used to adjust for multiple comparisons.
ACCESSION NUMBERS
The accession number for the Microbial shotgun and 16S sequences reported in this paper is the European Nucleotide Archive (ENA): PRJEB11300. 
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